Loading...
XJPX6856
Market cap2.43bUSD
Dec 24, Last price  
9,108.00JPY
1D
0.11%
1Q
-1.43%
Jan 2017
68.35%
Name

Horiba Ltd

Chart & Performance

D1W1MN
XJPX:6856 chart
P/E
9.48
P/S
1.32
EPS
960.66
Div Yield, %
2.87%
Shrs. gr., 5y
0.06%
Rev. gr., 5y
6.65%
Revenues
290.56b
+7.56%
92,492,497,000105,664,560,000116,099,308,000144,283,000,000134,247,000,000104,538,000,000118,556,000,000123,456,000,000117,609,000,000138,136,000,000153,065,000,000170,898,000,000170,093,000,000195,399,000,000210,570,000,000200,241,000,000187,080,000,000224,314,000,000270,133,000,000290,558,000,000
Net income
40.30b
+18.28%
3,523,744,0006,473,422,0006,510,280,0008,690,000,0006,039,000,0003,161,000,0007,927,000,0008,664,000,0007,396,000,0008,999,000,00010,589,000,00012,882,000,00012,962,000,00016,281,000,00022,313,000,00015,481,000,00013,188,000,00021,311,000,00034,072,000,00040,302,000,000
CFO
16.65b
-50.97%
7,215,949,0008,672,639,0003,769,542,00013,581,000,0007,521,000,00013,711,000,00011,964,000,0006,954,000,00013,395,000,00015,076,000,00011,455,000,00014,770,000,00015,871,000,00028,287,000,00019,536,000,00026,638,000,00032,253,000,00035,268,000,00033,966,000,00016,652,000,000
Dividend
Dec 27, 2024185 JPY/sh
Earnings
Feb 12, 2025

Profile

HORIBA, Ltd. manufactures and sells instruments and systems for various applications. It operates in five segments: Automotive, Process & Environmental, Medical-Diagnostic, Semiconductor, and Scientific. The Automotive segment offers automotive emission analyzers, emission measurement systems, drive line test systems, engine test and fuel cell test systems, and battery test systems; test systems for engines, chassis, powertrains, brakes, and catalysts; and vehicle development engineering and testing engineering services, as well as leases and manages R&D facilities. The Process & Environmental segment provides stack gas analyzers, industrial water quality analyzers, water quality analysis and examination systems, air pollution analyzers, environmental radiation meters, and process measurement equipment. The Medical-Diagnostic segment offers hematology and CRP, immunology, clinical chemistry, and blood glucose analyzers. The Semiconductor Instruments & Systems segment provides mass flow controllers, chemical concentration monitors, reticle/mask particle detection systems, residual gas analyzers, and vaporizers. The Scientific segment offers Raman spectrometers, pH meters, particle-size distribution analyzers, X-Ray fluorescence analyzers, elemental analyzers, fluorescence spectroscopy/fluorescence lifetime spectroscopy, optical components, spectrometers and detectors, and gratings. The company was founded in 1945 and is headquartered in Kyoto, Japan.
URL
https://www.horiba.com/int/
IPO date
Mar 22, 1971
Employees
8,432
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
290,558,000
7.56%
270,133,000
20.43%
224,314,000
19.90%
Cost of revenue
183,610,000
172,044,000
147,801,000
Unusual Expense (Income)
NOPBT
106,948,000
98,089,000
76,513,000
NOPBT Margin
36.81%
36.31%
34.11%
Operating Taxes
13,400,000
13,199,000
8,891,000
Tax Rate
12.53%
13.46%
11.62%
NOPAT
93,548,000
84,890,000
67,622,000
Net income
40,302,000
18.28%
34,072,000
59.88%
21,311,000
61.59%
Dividends
(10,973,000)
(6,959,000)
(4,637,000)
Dividend yield
2.34%
2.86%
1.62%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
5,695,000
12,351,000
25,107,000
Long-term debt
57,429,000
57,573,000
57,432,000
Deferred revenue
2,107,000
Other long-term liabilities
8,905,000
7,541,000
6,040,000
Net debt
(87,317,000)
(80,406,000)
(64,971,000)
Cash flow
Cash from operating activities
16,652,000
33,966,000
35,268,000
CAPEX
(8,849,000)
(12,083,000)
(12,572,000)
Cash from investing activities
(7,315,000)
(10,745,000)
(14,662,000)
Cash from financing activities
(20,963,000)
(22,447,000)
(4,045,000)
FCF
49,535,000
66,152,000
61,622,000
Balance
Cash
134,775,000
141,354,000
137,035,000
Long term investments
15,666,000
8,976,000
10,475,000
Excess cash
135,913,100
136,823,350
136,294,300
Stockholders' equity
266,001,000
223,356,000
187,190,000
Invested Capital
217,115,900
169,637,650
148,895,700
ROIC
48.38%
53.30%
46.15%
ROCE
30.24%
31.87%
26.67%
EV
Common stock shares outstanding
42,475
42,437
42,414
Price
11,030.00
92.50%
5,730.00
-15.24%
6,760.00
11.74%
Market cap
468,499,250
92.67%
243,164,010
-15.19%
286,718,640
11.79%
EV
381,199,250
162,773,010
221,759,640
EBITDA
119,550,000
109,437,000
86,953,000
EV/EBITDA
3.19
1.49
2.55
Interest
722,000
657,000
516,000
Interest/NOPBT
0.68%
0.67%
0.67%